Hepion Pharmaceuticals logo

Hepion Pharmaceuticals Share Price Today

(NASDAQ: HEPA)

Hepion Pharmaceuticals share price is $0.09 & ₹7.84 as on 6 Mar 2025, 2.30 'hrs' IST

$0.09

-0.01

(-12.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Hepion Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Hepion Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Hepion Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Hepion Pharmaceuticals share price movements

  • Today's Low: $0.09
    Today's High: $0.11

    Day's Volatility :19.66%

  • 52 Weeks Low: $0.08
    52 Weeks High: $2.90

    52 Weeks Volatility :97.24%

Hepion Pharmaceuticals (HEPA) Returns

PeriodHepion Pharmaceuticals IncIndex (Russel 2000)
3 Months
-85.83%
0.0%
6 Months
-88.22%
0.0%
1 Year
-96.1%
0.0%
3 Years
-99.61%
-11.6%

Hepion Pharmaceuticals (HEPA) Key Statistics

in dollars & INR

Previous Close
$0.1016
Open
$0.097
Today's High
$0.1068
Today's Low
$0.0858
Market Capitalization
$1.1M
Today's Volume
$8.6M
52 Week High
$2.8999
52 Week Low
$0.080001
Revenue TTM
$0.0
EBITDA
$-25.3M
Earnings Per Share (EPS)
$-3.92
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-288.27%

How to invest in Hepion Pharmaceuticals Stock (HEPA) from India?

It is very easy for Indian residents to invest directly in Hepion Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Hepion Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Hepion Pharmaceuticals or HEPA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Hepion Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Hepion Pharmaceuticals shares which would translate to 9.674 fractional shares of Hepion Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Hepion Pharmaceuticals, in just a few clicks!

Returns in Hepion Pharmaceuticals (HEPA) for Indian investors in Rupees

The Hepion Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Hepion Pharmaceuticals investment value today

Current value as on today

₹8,995

Returns

₹91,005

(-91.01%)

Returns from Hepion Pharmaceuticals Stock

₹96,070 (-96.07%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Hepion Pharmaceuticals (HEPA)

-78.12%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Hepion Pharmaceuticals Shares from India has dropped by -78.12% over the past 30 days, indicating reduced transactional activity.

-61%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Hepion Pharmaceuticals Stock from India on INDmoney has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Hepion Pharmaceuticals

  • Anson Funds Management LP

    2.18%

  • BlackRock Inc

    0.78%

  • Vanguard Group Inc

    0.47%

  • Geode Capital Management, LLC

    0.43%

  • Susquehanna International Group, LLP

    0.25%

  • Renaissance Technologies Corp

    0.16%

Analyst Recommendation on Hepion Pharmaceuticals

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Hepion Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Hepion Pharmaceuticals Stock (HEPA)

What analysts predicted

Upside of 33233.33%

Target:

$30.00

Current:

$0.09

Insights on Hepion Pharmaceuticals Stock (Ticker Symbol: HEPA)

  • Price Movement

    In the last 7 days, HEPA stock has moved down by -37.1%
  • HEPA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 162.6%
  • HEPA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 151.2%

Hepion Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Hepion Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Hepion Pharmaceuticals (HEPA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Hepion Pharmaceuticals Inc logo
-47.84%
-88.22%
-96.1%
-99.61%
-99.8%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Hepion Pharmaceuticals Inc logo
NA
NA
NA
0.0
-2.88
-1.1
NA
-0.3
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Hepion Pharmaceuticals Inc logo
Buy
$1.1M
-99.8%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Hepion Pharmaceuticals

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
Organization
Hepion Pharmaceuticals
Employees
22
CEO
Mr. John Patrick Brancaccio CPA
Industry
Health Technology

Management People of Hepion Pharmaceuticals

NameTitle
Mr. John Patrick Brancaccio CPA
Interim CEO, Interim CFO & Chairman of the Board
Sharen Pyatetskaya
Director of Investor Relations

Important FAQs about investing in HEPA Stock from India :

What is Hepion Pharmaceuticals share price today?

Hepion Pharmaceuticals share price today stands at $0.09, Open: $0.10 ; Previous Close: $0.10 ; High: $0.11 ; Low: $0.09 ; 52 Week High: $2.90 ; 52 Week Low: $0.08.

The stock opens at $0.10, after a previous close of $0.10. The stock reached a daily high of $0.11 and a low of $0.09, with a 52-week high of $2.90 and a 52-week low of $0.08.

Can Indians buy Hepion Pharmaceuticals shares?

Yes, Indians can invest in the Hepion Pharmaceuticals (HEPA) from India.

With INDmoney, you can buy Hepion Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Hepion Pharmaceuticals at zero transaction cost.

How can I buy Hepion Pharmaceuticals shares from India?

It is very easy to buy Hepion Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Hepion Pharmaceuticals (HEPA) be purchased?

Yes, you can buy fractional shares of Hepion Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Hepion Pharmaceuticals stocks?

To start investing in Hepion Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Hepion Pharmaceuticals Stock (HEPA)?

Today’s highest price of Hepion Pharmaceuticals (HEPA) is $0.11.

Today’s lowest price of Hepion Pharmaceuticals (HEPA) is $0.09.

What is today's market capitalisation of Hepion Pharmaceuticals?

Today's market capitalisation of Hepion Pharmaceuticals HEPA is 1.1M

What is the 52 Week High and Low Range of Hepion Pharmaceuticals Stock (HEPA)?

  • 52 Week High

    $2.90

  • 52 Week Low

    $0.08

What are the historical returns of Hepion Pharmaceuticals (HEPA)?

  • 1 Month Returns

    -47.84%

  • 3 Months Returns

    -88.22%

  • 1 Year Returns

    -96.1%

  • 5 Years Returns

    -99.8%

Who is the Chief Executive Officer (CEO) of Hepion Pharmaceuticals ?

Mr. John Patrick Brancaccio CPA is the current Chief Executive Officer (CEO) of Hepion Pharmaceuticals.